{
	"root": [
		{
			"id": 0,
			"parent": -1,
			"text": "ROOT",
			"relation": "null"
		},
		{
			"id": 1,
			"parent": 4,
			"text": "Vaccination with synthetic peptides",
			"relation": "BACKGROUND"
		},
		{
			"id": 2,
			"parent": 1,
			"text": "representing cytotoxic T lymphocyte ( CTL ) epitopes",
			"relation": "ELABORATION"
		},
		{
			"id": 3,
			"parent": 1,
			"text": "can lead to a protective CTL-mediated immunity against tumors or viruses . <S>",
			"relation": "SAME-UNIT"
		},
		{
			"id": 4,
			"parent": 0,
			"text": "We now report that vaccination with a CTL epitope",
			"relation": "ROOT"
		},
		{
			"id": 5,
			"parent": 4,
			"text": "derived from the human adenovirus type 5 E1A-region ( Ad5E1A234-243 ) ,",
			"relation": "CAUSE-RESULT"
		},
		{
			"id": 6,
			"parent": 5,
			"text": "which can serve as a target for tumor-eradicating CTL ,",
			"relation": "ELABORATION"
		},
		{
			"id": 7,
			"parent": 4,
			"text": "enhances rather than inhibits the growth of Ad5E1A-expressing tumors . <S>",
			"relation": "SAME-UNIT"
		},
		{
			"id": 8,
			"parent": 4,
			"text": "This adverse effect of peptide vaccination was rapidly evoked ,",
			"relation": "ELABORATION"
		},
		{
			"id": 9,
			"parent": 8,
			"text": "required low doses of peptide",
			"relation": "ADDITION"
		},
		{
			"id": 10,
			"parent": 9,
			"text": "( 10 micrograms ) ,",
			"relation": "ELABORATION"
		},
		{
			"id": 11,
			"parent": 9,
			"text": "and was achieved by a mode of peptide delivery",
			"relation": "ADDITION"
		},
		{
			"id": 12,
			"parent": 11,
			"text": "that induces protective T-cell-mediated immunity in other models . <S>",
			"relation": "ELABORATION"
		},
		{
			"id": 13,
			"parent": 8,
			"text": "Ad5E1A-specific CTL activity could no longer be isolated from mice after injection of Ad5E1A-peptide ,",
			"relation": "ADDITION"
		},
		{
			"id": 14,
			"parent": 13,
			"text": "indicating that tolerization of Ad5E1A-specific CTL activity causes the enhanced tumor outgrowth . <S>",
			"relation": "CAUSE-RESULT"
		},
		{
			"id": 15,
			"parent": 16,
			"text": "In contrast to peptide vaccination ,",
			"relation": "COMPARISON"
		},
		{
			"id": 16,
			"parent": 13,
			"text": "immunization with adenovirus ,",
			"relation": "ADDITION"
		},
		{
			"id": 17,
			"parent": 16,
			"text": "expressing Ad5E1A ,",
			"relation": "ELABORATION"
		},
		{
			"id": 18,
			"parent": 16,
			"text": "induced Ad5E1A-specific immunity",
			"relation": "SAME-UNIT"
		},
		{
			"id": 19,
			"parent": 16,
			"text": "and prevented the outgrowth of Ad5E1A-expressing tumors . <S>",
			"relation": "ADDITION"
		},
		{
			"id": 20,
			"parent": 4,
			"text": "These results show that immunization with synthetic peptides can lead to the elimination of anti-tumor CTL responses . <S>",
			"relation": "FINDINGS"
		},
		{
			"id": 21,
			"parent": 20,
			"text": "These findings are important for the design of safe peptide-based vaccines against tumors , allogeneic organ transplants , and T-cell-mediated autoimmune diseases . <S>",
			"relation": "ADDITION"
		}
	]
}